Article | Regulation | Jul 10, 2018

      When science meets law

      TIME TO READ: 1 MIN

      In March 2018, Philip Morris New Zealand participated in a trial to determine whether selling the Tobacco Heating System (THS) and associated tobacco units in New Zealand was in violation of the country’s Smoke-Free Environments Act, 1990.

      The question to be answered was whether commercializing the product was at odds with the purpose of the Act, which is to reduce the harmful effects of tobacco products and reduce exposure of nonsmokers to passive smoking. Science played a key role in the evidence that was considered by the court. Philip Morris New Zealand submitted evidence from Dr. Moira Gilchrist, PMI’s Vice President of Scientific and Public Communications, summarizing our scientific assessment of THS.

      The New Zealand Ministry of Health presented evidence from an independent scientific expert witness who was requested to give an opinion on whether combustion occurs during the operation of THS. This witness found that “no combustion or other exothermic processes were observed in the operation of the … device.”

      The Court concluded that THS “while it may have associated risks in itself, is not as harmful or potentially harmful as ordinary cigarette use. This finding would fit squarely with the purposes … of the Act.” The Court also concluded that the law was intended to ban smokeless tobacco for oral use, it does not apply to THS. It deemed that banning the sale of THS would be inconsistent with the objectives of the Smoke-Free Environments Act, including “to reduce some of the harmful effects of tobacco products on the health of users by monitoring and regulating the presence of harmful substances in the smoke.” 

      It is encouraging to see that science played a pivotal role in the decision of the court.

      Related Articles
      Cube, PMI's research and development center located in Neuchâtel, Switzerland.
      PMI Presents to US FDA Advisory Committee
      The presentation covers: THS heating technology, assessment results, perception & behavior data, plans to introduce THS in the U.S., and population health impact modeling.
      Blue outline on Greece on white background
      Greek MOH approves differentiated health claims for heated tobacco
      See the health statement that the Greek Ministry of Health approved for our leading heated tobacco product.
      Person sitting on a chair and reading scientific book.
      Regulation of smoke-free products
      Advanced technological and scientific solutions require advanced regulatory tools.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.